Influence of Suppressor of Cytokine Signaling 1 (SOCS1) Gene Variations on Polycystic Ovary Syndrome

被引:0
|
作者
Rakhshanizade, Niloufar [1 ]
Sargazi, Saman [2 ,3 ]
Karajibani, Mansour [1 ,4 ]
Majidpour, Mahdi [5 ]
Karajibani, Atena [6 ]
Montazerifar, Farzaneh [1 ,4 ]
Ghasemi, Marzieh [7 ,8 ]
机构
[1] Zahedan Univ Med Sci, Sch Med, Dept Nutr, Zahedan, Iran
[2] Zahedan Univ Med Sci, Res Inst Cellular & Mol Sci Infect Dis, Cellular & Mol Res Ctr, Zahedan, Iran
[3] Zahedan Univ Med Sci, Sch Med, Dept Clin Biochem, Zahedan, Iran
[4] Zahedan Univ Med Sci, Hlth Promot Res Ctr, Zahedan, Iran
[5] Zahedan Univ Med Sci, Clin Immunol Res Ctr, Zahedan, Iran
[6] Univ Sistan & Baluchestan, Dept Biol, Zahedan, Iran
[7] Zahedan Univ Med Sci, Pregnancy Hlth Res Ctr, Zahedan, Iran
[8] Zahedan Univ Med Sci, Ali ibn Abitaleb Hosp, Moloud Infertil Ctr, Zahedan, Iran
关键词
SOCS1; Gene polymorphism; Polycystic ovarian syndrome; Cytokine signaling; INSULIN-RESISTANCE; ASSOCIATION; POLYMORPHISMS; EXPRESSION; CRITERIA; PREVALENCE; PHENOTYPES; VARIANTS; PCOS;
D O I
10.1007/s12291-024-01248-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polycystic ovarian syndrome (PCOS) is associated with low-grade systemic inflammation and an increase in inflammation markers, which are crucial in managing ovarian function. This study aimed to determine whether SOCS1 gene variants are associated with PCOS risk. In total, 300 subjects were enrolled (150 patients with PCOS and 150 healthy individuals). Each subject's peripheral blood was collected for genomic DNAs isolation and biochemical assessments. After adjustment for BMI, codominant heterozygous [OR = 0.45, 95%CI = 0.27-0.77], codominant homozygous [OR = 0.29, 95%CI = 0.11-0.76], dominant [OR = 0.39, 95%CI = 0.23-0.65], and overdominant [OR = 0.50, 95%CI = 0.29-0.84] models of rs33932899, as well as the codominant homozygous [OR = 0.26, 95%CI = 0.10-0.69], dominant [OR = 0.55, 95%CI = 0.34-0.89], and recessive [OR = 0.33, 95%CI = 0.12-0.87] genetic patterns of rs243327 were significantly associated with decreased PCOS risk. On the contrary, codominant homozygous [OR = 2.40, 95%CI = 1.20-4.78] and recessive [OR = 2.10, 95%CI = 1.14-3.87] modes of the rs33989964 variation increased PCOS risk (P-value < 0.05). Analysis of the interaction demonstrated that the GG/Del-Del/CC genotype combination of rs33932899/rs33989964/rs243327 significantly increased the risk of PCOS in our population [OR = 4.81, 95%CI = 1.72-13.49]. Furthermore, the G(rs33932899)TG(rs33989964)C(rs243327) and C(rs33932899)Del(rs33989964)C(rs243327) and C(rs33932899)Del(rs33989964)T(rs243327) haplotypes were associated with the risk of PCOS (p = 0.007, p < 0.001 and p = 0.012 respectively). A significant difference has also been observed between cases carrying GG + GC genotypes of rs33932899 regarding fasting blood sugar levels (P-value < 0.05). The SOSC1 rs33989964 variation increased PCOS risk, while both SOSC1 rs33932899 and rs243327 variants conferred protection against PCOS in our population. Additional research on various racial groups is needed to determine if these variations contribute to PCOS, a complicated hormonal disorder with multiple factors. [GRAPHICS]
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis
    Mafanda, Euphrasie Kawila
    Kandhi, Rajani
    Bobbala, Diwakar
    Khan, Md Gulam Musawwir
    Nandi, Madhuparna
    Menendez, Alfredo
    Ramanathan, Sheela
    Ilangumaran, Subburaj
    CYTOKINE, 2019, 124
  • [22] The SOCS box of suppressor of cytokine signalling 1 (SOCS1) is essential for full inhibition of cytokine signalling in vivo
    Alexander, W
    Zhang, J
    Metcalf, D
    Nicola, N
    Hilton, D
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 78 - 78
  • [23] Suppressor of Cytokine Signaling-1 (SOCS1) Inhibits Lymphocyte Recruitment into the Retina and Protects SOCS1 Transgenic Rats and Mice from Ocular Inflammation
    Yu, Cheng-Rong
    Mahdi, Rashid R.
    Oh, Hyun-Mee
    Amadi-Obi, Ahjoku
    Levy-Clarke, Grace
    Burton, Jenna
    Eseonu, Amarachi
    Lee, YongJun
    Chan, Chi-Chao
    Egwuagu, Charles E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (09) : 6978 - 6986
  • [24] HTLV-1 Evades Type I Interferon Antiviral Signaling by Inducing the Suppressor of Cytokine Signaling 1 (SOCS1)
    Oliere, Stephanie
    Hernandez, Eduardo
    Lezin, Agnes
    Arguello, Meztli
    Douville, Renee
    Nguyen, Thi Lien-Anh
    Olindo, Stephane
    Panelatti, Gerard
    Kazanji, Mirdad
    Wilkinson, Peter
    Sekaly, Rafick-Pierre
    Cesaire, Raymond
    Hiscott, John
    PLOS PATHOGENS, 2010, 6 (11)
  • [25] Suppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma response
    Lee, C.
    Kolesnik, T. B.
    Caminschi, I.
    Chakravorty, A.
    Carter, W.
    Alexander, W. S.
    Jones, J.
    Anderson, G. P.
    Nicholson, S. E.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (06): : 897 - 907
  • [26] Suppressor of Cytokine Signaling-1 (SOCS1): A Potential Mechanistic Target for the Study of Preeclampsia Development.
    Wilson, Tenisha Denise
    Shaddeau, Angela
    Lei, Jun
    Chudnovets, Anna
    Elsayed, Nada
    Boyer, Theresa
    Burd, Irina
    Vaught, Arthur
    REPRODUCTIVE SCIENCES, 2020, 27 (SUPPL 1) : 352A - 352A
  • [27] Expression of suppressor of cytokine signaling 1 (SOCS1) impairs immune defense against influenza infection.
    Sun, Keer
    Metzger, Dennis
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [28] The Suppressor of Cytokine Signaling-1 (SOCS-1)
    Metcalf, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 19 - 19
  • [29] Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling
    Gingras, S
    Parganas, E
    de Pauw, A
    Ihle, JN
    Murray, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) : 54702 - 54707
  • [30] Intracellular regulation of cytokine signalling on migraine: Suppressor of Cytokine Signaling1(SOCS1) inhibits the JAK/STAT signalling pathway
    Realacci, M
    Zicari, A
    Sant'Angelo, C
    Denora, P
    De Filippis, S
    Coloprisco, G
    Rodio, A
    Fiore, G
    Santi, PG
    Martelletti, P
    CEPHALALGIA, 2003, 23 (07) : 638 - 638